Juan Molina

Dr. Juan Molina


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2022 in Toxins
Verified
Journal Article
Open access
PDF file
ANAna Navas
Ana Navas
Berta Ruiz-LeónBerta Ruiz-León
Berta Ruiz-León
PSPilar Serrano
Pilar Serrano
MAManuel Martí Antonio
Manuel Martí Antonio
MEM Luisa Espinazo
M Luisa Espinazo
Carmen Moreno-AguilarCarmen Moreno-Aguilar
Carmen Moreno-Aguilar
Inducing tolerance in Hymenoptera-allergic patients, bee venom immunotherapy (BVIT) is a widely accepted method to treat severe allergy to bee stings. In order to increase the existing knowledge on the underlying immunological mechanisms and look for possible biomarkers predictive of efficacy, a group of 20 bee-venom-allergic patients (AG) were thoroughly examined during their first year of BVIT. In addition, the results of treated patients with those of an untreated group of 20 tolerant beekeepers (TG) who had previously shown a firm suppressor-regulatory profile were compared. Tolerance in AG patients was invariably associated with a significant regulatory response characterised by the expansion of Helios− subpopulation and increased IL-10, specific IgG4 (sIgG4), and kynurenine levels. Although specific IgE (sIgE) levels increased transiently, surprisingly, the T helper type 2 (Th2) population and IL-4 levels rose significantly after one year of immunotherapy. Thus, the picture of two parallel phenomena emerges: a tolerogenic response and an allergenic one. Comparing these results with those obtained from the TG, different immunological mechanisms appear to govern natural and acquired tolerance to immunotherapy. Of particular interest, the kynurenine levels and T regulatory (Treg) Helios− population could be proposed as new biomarkers of response to BVIT.

27 August 2024 in Nutrients
Verified
Journal Article
Open access
PDF file
PÁPaula Álvarez-Romero
Paula Álvarez-Romero
RARocio Aguado
Rocio Aguado
JMJuan Molina
Juan Molina
ATAntonio Trujillo-Aguilera
Antonio Trujillo-Aguilera
MVMayte Villalba
Mayte Villalba
Aurora Jurado RogerAurora Jurado Roger
Aurora Jurado Roger
Background: Cross-reactivity between nonspecific lipid transfer proteins could cause anaphylaxis, further influencing food avoidance and nutrient deficiencies. The one affecting olive pollen (Ole e 7) and peach (Pru p 3) may underlie a variety of pollen-food syndromes, though a deep molecular analysis is necessary. Methods: Three Ole e 7-monosensitised patients (MON_OLE), three Pru p 3-monosensitised patients (MON_PRU) and three bisensitised patients (BI) were selected. For epitope mapping, both digested proteins were incubated with patient sera, and the captured IgE-bound peptides were characterised by LC-MS. Results: The analysis revealed two Ole e 7 epitopes and the three Pru p 3 epitopes previously described. Interestingly, the “KSALALVGNKV” Ole e 7 peptide was recognised by MON_OLE, BI and MON_PRU patients. Conversely, all patients recognised the “ISASTNCATVK” Pru p 3 peptide. Although complete sequence alignment between both proteins revealed 32.6% identity, local alignment considering seven residue fragments showed 50 and 57% identity when comparing “ISASTNCATVK” with Ole e 7 and “KSALALVGNKV” with Pru p 3. Conclusions: This study mapped sIgE-Ole e 7-binding epitopes, paving the way for more precise diagnostic tools. Assuming non-significant sequence similarity, structural homology and shared key residues may underlie the potential cross-reactivity between Ole e 7 and Pru p 3 nsLTPs.

24 October 2025 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
PÁPaula Álvarez
Paula Álvarez
ANAna Navas
Ana Navas
MMManuel Martí-Antonio
Manuel Martí-Antonio
RBRaquel Bernardo
Raquel Bernardo
ATAntonio Trujillo-Aguilera
Antonio Trujillo-Aguilera
AJAurora Jurado
Aurora Jurado
Although the SARS-Cov-2 pandemic has passed, the virus continues to cause infection and death. Immunological response is crucial to overcome the disease. Elucidating the prognostic value of measurable immunological variables at the time of admission and throughout the disease progression could provide stratification tools, improving the management of patients. A total of 1,096 samples belonging to 979 hospitalised patients molecularly diagnosed with SARS-CoV-2 infection, together with their medical records were retrospectively analysed. Demographic data, including age, sex, date of symptom onset and admission and T, B and NK cells and serum cytokine levels, were collected as predictor variables. Stratification of patients was performed according to their severity (grade 1: uncomplicated disease; grade 2: mild pneumonia; grade 3: severe pneumonia), their admission to Intensive Care Unit and their final outcome (death vs. alive). On admission, more severe patients were older, had lower lymphocyte subpopulation counts and higher levels of IL-6, IL-8, IL-10 and IP-10. The trend of lymphocyte counts throughout the disease progression since the symptom onset was to increase both in less and severe patients (even though in these last the levels remained significantly lower), except for NK cells, which decreased. Regarding cytokine levels, IL-6 and IL-8 tended to increase, whereas IL-10 and IP-10 tended to decrease in more severe patients, although particularly IL-10 remained significantly higher in them as compared with less severe patients, and, interestingly, its tendency was to increase in those who died. When considering the clinical evolution, an increase of IL-8 serum levels and a decrease of NK cells were significantly associated with a worsening, while an increase of CD19+ B and CD8+ T cells and a decrease of IL-6, IL-10, MCP-1 and IP-10 cytokine circulating levels were significantly related to an improvement. By integrating all the results, 13 optimal classification trees were constructed using evolutionary algorithms to predict COVID-19 outcome. The age and the study of lymphocyte populations in a county hospital, together with cytokine serum level quantitation in a third-level hospital, are enough variables to predict the outcome of patients hospitalised due to SARS-CoV-2 infection.

Verified
Journal Article
Open access
PDF file
PÁPaula Álvarez-Romero
Paula Álvarez-Romero
JMJuan Molina
Juan Molina
RBRaquel Bernardo
Raquel Bernardo
RGRafael González
Rafael González
BMBárbara Manzanares
Bárbara Manzanares
ANAna Navas
Ana Navas
Concomitant sensitisation to non-specific lipid transfer proteins (nsLTPs) from olive pollen (Ole e 7) and peach (Pru p 3) has been observed in the south of Spain. In the search for reasons to explain this observation, we studied a potential causal relationship between Human Leukocyte Antigen (HLA) molecules and nsLTP sensitisation. For this purpose, eighteen Ole e 7-monosensitised (MONOLE) patients, 22 Pru p 3-monosensitised (MONPRU) patients, and 22 bisensitised (BI) patients were genotyped for HLA class II alleles. Complementarily, T-cell epitopes were predicted with the Immune Epitope Database analysis tool to test HLA epitope presentation. Our results showed a significant increase in DRB1*11 and DQB1*03 frequencies in MONPRU patients and DRB1*04 frequency in MONOLE patients. Additionally, T-cell epitope analysis revealed high binding affinity between the predicted Pru p 3 epitopes and DRB1*11 and between the predicted Ole e 7 epitopes and DRB1*04, suggesting that presentation of these epitopes may be favoured and predisposing individuals to sensitisation. Conversely, low DQB1*05 frequency and poor binding ability of predicted epitopes from both nsLTPs postulated this allele as a possible protective factor to sensitisation. Variations in the binding affinity between nsLTP epitopes and HLA molecules may underlie individual susceptibility to nsLTP allergy.